Multivessel PCI for Acute Myocardial Infarction: Where Do We Stand After The COMPLETE Trial?
Akram Y ElgendyDhruv MahttaDavid PaniaguaPublished in: Current cardiology reports (2020)
The Complete versus Culprit-only Revascularization to Treat Multi-vessel disease after Early PCI for STEMI (COMPLETE) trial recently showed that a complete revascularization strategy for non-culprit stenoses for STEMI patients without cardiogenic shock, performed either during the index hospitalization or after discharge, reduces the risk of cardiac mortality or myocardial infarction (MI) driven by a reduction in the risk of MI at a median of 3 years. In STEMI patients without cardiogenic shock undergoing primary PCI, a complete revascularization strategy for non-culprit stenoses, performed either during the index hospitalization or shortly after discharge, improves outcomes and should be considered as the default strategy whenever feasible.
Keyphrases
- percutaneous coronary intervention
- acute myocardial infarction
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- coronary artery bypass grafting
- coronary artery disease
- acute coronary syndrome
- antiplatelet therapy
- end stage renal disease
- ejection fraction
- newly diagnosed
- left ventricular
- clinical trial
- atrial fibrillation
- peritoneal dialysis
- study protocol
- phase iii
- cardiovascular disease
- coronary artery bypass
- risk factors
- cardiovascular events
- insulin resistance
- skeletal muscle
- glycemic control
- open label